Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$5.33 USD
-0.12 (-2.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.30 -0.03 (-0.56%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.56 | 0.00% |
Earnings Summary
For their last quarter, Monte Rosa Therapeutics (GLUE) reported earnings of -$0.58 per share, missing the Zacks Consensus Estimate of -$0.57 per share. This reflects a negative earnings surprise of 1.75%. Look out for GLUE's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.56 per share, reflecting a year-over-year increase of 13.85%.
Earnings History
Price & Consensus
Zacks News for GLUE
Does Monte Rosa Therapeutics (GLUE) Have the Potential to Rally 107.79% as Wall Street Analysts Expect?
GLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services